Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSIW) Tax Provisions (2022 - 2025)

TriSalus Life Sciences' Tax Provisions history spans 4 years, with the latest figure at $5000.0 for Q3 2025.

  • For Q3 2025, Tax Provisions rose 266.67% year-over-year to $5000.0; the TTM value through Dec 2025 reached $7000.0, up 16.67%, while the annual FY2025 figure was $7000.0, 16.67% up from the prior year.
  • Tax Provisions reached $5000.0 in Q3 2025 per TLSIW's latest filing, up from -$3000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $28202.0 in Q2 2022 to a low of -$5000.0 in Q1 2023.
  • Average Tax Provisions over 4 years is $4683.5, with a median of $4000.0 recorded in 2024.
  • Peak YoY movement for Tax Provisions: plummeted 200.0% in 2024, then soared 266.67% in 2025.
  • A 4-year view of Tax Provisions shows it stood at $6000.0 in 2022, then plummeted by 83.33% to $1000.0 in 2023, then tumbled by 200.0% to -$1000.0 in 2024, then skyrocketed by 600.0% to $5000.0 in 2025.
  • Per Business Quant, the three most recent readings for TLSIW's Tax Provisions are $5000.0 (Q3 2025), -$3000.0 (Q2 2025), and $5000.0 (Q1 2025).